Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

MitoMedical Launches Public Education Initiative on Mitochondrial Dysfunction: What Parents Need to Know
  • USA - English


News provided by

Gale Branding

Jun 29, 2016, 03:00 ET

Share this article

Share toX

Share this article

Share toX


Mitochondrial dysfunction could explain brain dysfunction in many children with autism as well as explain why many other medical disorders, such as gastrointestinal and immune dysfunction are also associated with autism. Dr. Richard Frye, M.D. Ph.D.

Post this

New York, NY (PRWEB) June 29, 2016 -- The mitochondria is one of the most important and often overlooked organelles in the body. It is essential for generating energy that powers every function in every cell of our bodies. Problems with the mitochondria create problems for the whole body – in particular the brain, which uses huge amounts of energy to function properly. Mitochondria play an important role in maintaining healthy blood sugar levels, as well as metabolic and cognitive function. When mitochondria do not work properly, this is referred to as mitochondrial dysfunction. In 2012, Dr. Richard E. Frye, M.D., Ph.D., director of autism research at Arkansas Children’s Hospital Research Institute, co-authored a systematic review compiling the results of 18 different studies and found that 30 percent or more of those with autism had blood tests indicating mitochondrial dysfunction. [1] However, treatment for mitochondrial dysfunction with supplements has remained widely unexploited due to the large quantities and often poor taste of combined ingredients required to attain the correct dosage.

“Mitochondrial dysfunction could explain brain dysfunction in many children with autism as well as explain why many other medical disorders, such as gastrointestinal and immune dysfunction, are also associated with autism,” says Dr. Richard Frye, M.D. Ph.D., associate professor, Department of Pediatrics, University of Arkansas for Medical Studies, College of Medicine

Taking notice of this research, Michelle Hasson, a senior executive with more than 20 years experience in evaluating new medical products, saw an opportunity. She turned to Dr. Suzanne Goh, M.D. MBA., former co-director of the Columbia University Developmental Neuropsychiatry Clinic for Autism and Related Disorders, to help her create a product that anyone could easily consume. Shortly there after, MitoMedical was founded to identify state-of-the-art practices to use towards the development of effective products that support healthy mitochondrial function in children and adults.

“Physicians at leading medical centers have been recommending mitochondrial supplements for decades,” says Michelle Hasson, CEO, MitoMedical, “The problem for many has been getting the required dose in a format that is easy for anyone to consume, so we set out to change that.”

MitoSpectra is the first product available to consumers using the mitochondrial cocktail developed at the Kennedy Krieger Institute of John Hopkins University by Dr. Richard Kelley, M.D. Ph.D., a leading authority in biochemical analysis. [2] MitoSpectra takes this formulation and makes it available in a format that all individuals, even those with high sensitivity to taste and texture, can easily consume. The next challenge MitoMedical seeks to tackle is a PR campaign aimed at educating the public on mitochondrial health and the important role it plays in overall wellbeing, proper cognitive function, and neurological development in children and adults alike.

“In order to get the same dose one would have to take more than 40 individual vitamins, minerals and supplements to achieve the same amount of active ingredients contained in just eight MitoSpectra capsules,” remarks Dr. Suzanne Goh, Medical Director for MitoMedical

Footnotes:
[1] Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis, Dr. Dan Rossignol and Dr. Richard E. Frye, Molecular Psychiatry, 2012; 17: 290-314.
[2] Evaluation and Treatment of Patients with Autism and Mitochondrial Disease, Richard I. Kelley, MD, PhD Division of Metabolism, Kennedy Krieger Institute Department of Pediatrics, Johns Hopkins Medical Institutions, June 13, 2009.

Additional research on this topic available here.

Product samples, interviews, expert quotes and press materials are available upon request.

MitoMedical, L.L.C. is a manufacturer, marketer and distributor of dietary supplements under strict adherence to FDA Good Manufacturing Practices. The company was founded in 2012 by CEO Michelle Hasson a senior executive leader with more than 20 years experience in evaluating prospects for new technologies and products within the medical industry. MitoMedical identifies state-of-the-art practices to use towards the development of effective products that support healthy mitochondrial function. The company’s research and development focuses on the biological correlation between mitochondrial dysfunction and neurological disorders such as autism spectrum disorder, ADHD and others. MitoMedical.com

MitoSpectra is a high potency dietary supplement formulated for children and adults to optimize the function of mitochondria. MitoSpectra’s formulation is based on a mitochondrial cocktail first developed by Dr. Richard Kelley, M.D., Ph.D, at the Kennedy Krieger Institute of John Hopkins University. MitoSpectra makes this formulation available in a format that all individuals, even those with high sensitivity to taste and texture, can consume easily. MitoSpectra is manufactured and distributed by MitoMedical under FDA Good Manufacturing Practices (FDA-GMP) at an FDAinspected facility in the United States. These standards ensure that all ingredients used in the product are pure, uncontaminated and that the final product contains the exact ingredients and strength. MitoMedical.com/Products

Dr. Suzanne Goh M.D. MBA., is the medical director for MitoMedical and is a board-certified pediatric neurologist with expertise in the evaluation and treatment of children with autism and other neurological conditions that impact brain development, cognition, and behavior. Before establishing Pediatric Neurology Therapeutics, her practice in San Diego California in 2013, Dr. Goh served as co-director of the Columbia University Developmental Neuropsychiatry Clinic for Autism and Related Disorders in New York City. She is a Rhodes Scholar and a graduate of Harvard Medical School. Dr. Goh has collaborated with the world-renowned developmental psychologist Dr. Marion Blank to create ASD Language, a series of programs to teach meaningful language and communication to children with autism and other developmental disorders. She is also co-author of the book Spectacular Bond: Reaching the Child with Autism. GohMD.org

Erik Bucci, Gale Branding, http://galebranding.com, +1 (212) 993-5815, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.